Peripheral Arterial Disease Trial, Recruiting (NCT06899113)

Peripheral Arterial Disease Trial, Recruiting NCT06899113 Sponsor: MIMOSA Diagnostics Inc. Condition: Peripheral Arterial Disease

Printed from Voxsanity (voxsanity.com.au) — NCT06899113 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Peripheral Arterial Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People aged 18 or older, of any gender
People who are willing to sign and date a consent form agreeing to take part
People who are willing to follow all study procedures and are available for the full length of the study
People who are having an ABI test (a non-invasive test that checks blood flow in the legs)
People who have recently had, or are scheduled to have, additional blood flow assessments as part of their usual care (such as oxygen level skin tests or ultrasound waveform tests)
People who are able to be seen and followed by the same medical team throughout the entire study period

Who may not be able to join:

People who are currently taking part in another clinical trial focused on wound or ulcer treatment
People who are not able to understand what the study involves or are not able to give informed consent
People who are currently receiving radiation treatment to an arm or leg
People who have active Charcot joints (a condition where bones in a joint, often the foot, become damaged and weakened)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 516-233-3780

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06899113

Sponsor: MIMOSA Diagnostics Inc.

Phase: Not Applicable

Status: Recruiting

Condition: Peripheral Arterial Disease

Trial contact: 516-233-3780

More information: https://clinicaltrials.gov/study/NCT06899113

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People aged 18 or older, of any gender
People who are willing to sign and date a consent form agreeing to take part
People who are willing to follow all study procedures and are available for the full length of the study
People who are having an ABI test (a non-invasive test that checks blood flow in the legs)
People who have recently had, or are scheduled to have, additional blood flow assessments as part of their usual care (such as oxygen level skin tests or ultrasound waveform tests)
People who are able to be seen and followed by the same medical team throughout the entire study period

Who may not be able to join:

People who are currently taking part in another clinical trial focused on wound or ulcer treatment
People who are not able to understand what the study involves or are not able to give informed consent
People who are currently receiving radiation treatment to an arm or leg
People who have active Charcot joints (a condition where bones in a joint, often the foot, become damaged and weakened)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

MIMOSA Diagnostics Inc.

Registry

ClinicalTrials.gov

Start date

13 May 2025

Est. completion

1 December 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Correlation coefficient between MIMOSA measures to standard vascular assessment modalities

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov